Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0159 Transporter Info | ||||
Gene Name | SLC23A2 | ||||
Transporter Name | Sodium-dependent vitamin C transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
CEBPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [1] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein alpha | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein alpha (CEBPA) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [2] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Bone | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [3] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
JUN |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC23A2 gene in K562 cells | [4] | ||||
TF Protein Name |
Transcription factor Jun | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor Jun (JUN) has been reported to bind to the transcription of SLC23A2 gene in K562 cells, which leads to an affected expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 8 TF(s) Regulating This DT |
|||||
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [5] | ||||
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Achaete-scute homolog 1 (ASCL1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
MITF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC23A2 gene in melanoma condition | [6] | ||||
TF Protein Name |
Microphthalmia-associated transcription factor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Microphthalmia-associated transcription factor (MITF) has been reported to activate the transcription of SLC23A2 gene in melanoma condition, which leads to an increased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
MYC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC23A2 gene in embryonic stem cells condition | [7] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) has been reported to bind to the transcription of SLC23A2 gene in embryonic stem cells condition, which leads to an affected expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
MYOD1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [5] | ||||
TF Protein Name |
Myoblast determination protein 1 | Transcription Factor Info | ||||
Tissue |
Myotube | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myoblast determination protein 1 (MYOD1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
TCF12 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [3] | ||||
TF Protein Name |
Transcription factor 12 | Transcription Factor Info | ||||
Tissue |
Blood; Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor 12 (TCF12) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [5] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
USF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [1] | ||||
TF Protein Name |
Upstream stimulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Colon; Embryo; Liver; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 1 (USF1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
USF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [2] | ||||
TF Protein Name |
Upstream stimulatory factor 2 | Transcription Factor Info | ||||
Tissue |
Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 2 (USF2) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TFAP2C |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [3] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Tissue |
Breast; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC23A2 gene in prostate cancer condition | [8] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC23A2 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC23A2 gene in health condition | [9] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC23A2 gene in health condition, which leads to an affected expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
HNF4G |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [2] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-gamma | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 4-gamma (HNF4G) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
NR2F2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [5] | ||||
TF Protein Name |
COUP transcription factor 2 | Transcription Factor Info | ||||
Tissue |
Breast; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
COUP transcription factor 2 (NR2F2) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [5] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC23A2 gene in gastric cancer condition | [10] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) has been reported to activate the transcription of SLC23A2 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
KLF9 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [3] | ||||
TF Protein Name |
Krueppel-like factor 9 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 9 (KLF9) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
SP1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC23A2 gene in brain neuroblastoma condition | [11] | ||||
TF Protein Name |
Transcription factor Sp1 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Ascorbic acid | |||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Transcription factor Sp1 (SP1) has been reported to activate the transcription of SLC23A2 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Transcriptional Phenomenon2 |
Activation of SLC23A2 gene in osteosarcoma condition | [12] | ||||
TF Protein Name |
Transcriptional repressor protein YY1 /Transcription factor Sp1 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Ascorbic acid | |||||
Studied Phenotype |
Osteosarcoma [ICD11: 2B51] | |||||
Tissue |
Bone | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human osteosarcoma cells (U2OS) | |||||
Detailed Description |
The transcriptional repressor protein YY1 (YY1) and the transcription factor Sp1 (SP1) have been reported to synergistically activate transcription of the SLC23A2 gene in osteosarcoma condition, which leads to an increased expression of the drug transporter sodium-dependent vitamin C transporter 2. | |||||
SP3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC23A2 gene in osteosarcoma condition | [12] | ||||
TF Protein Name |
Transcriptional repressor protein YY1 /Transcription factor Sp3 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Ascorbic acid | |||||
Studied Phenotype |
Osteosarcoma [ICD11: 2B51] | |||||
Tissue |
Bone | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human osteosarcoma cells (U2OS) | |||||
Detailed Description |
The transcriptional repressor protein YY1 (YY1) and the Transcription factor Sp3 (SP3) have been reported to synergistically activate transcription of the SLC23A2 gene in osteosarcoma condition, which leads to an increased expression of the drug transporter sodium-dependent vitamin C transporter 2. | |||||
WT1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC23A2 gene in podocyte condition | [13] | ||||
TF Protein Name |
Wilms tumor protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Wilms tumor protein (WT1) has been reported to activate the transcription of SLC23A2 gene in podocyte condition, which leads to an increased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
ZBTB7A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [1] | ||||
TF Protein Name |
Zinc finger and BTB domain-containing protein 7A | Transcription Factor Info | ||||
Tissue |
Bone marrow; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger and BTB domain-containing protein 7A (ZBTB7A) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
HNF1A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC23A2 gene in health condition | [14] | ||||
TF Protein Name |
Hepatocyte nuclear factor 1-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 1-alpha (HNF1A), influenced by the generated by the gut microbiota and Gram negative bacteria, has been reported to activate the transcription of SLC23A2 gene in health condition, which leads to an increased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
HNF1B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC23A2 gene in renal cysts condition | [15] | ||||
TF Protein Name |
Hepatocyte nuclear factor 1-beta | Transcription Factor Info | ||||
Studied Phenotype |
Renal cysts [ICD11: GB80] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Zebrafish TgPT::EGFP) | |||||
Detailed Description |
Hepatocyte nuclear factor 1-beta (HNF1B) has been reported to repress the transcription of SLC23A2 gene in renal cysts condition, which leads to a decreased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
NANOG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC23A2 gene in HESC condition | [16] | ||||
TF Protein Name |
Homeobox protein NANOG | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Homeobox protein NANOG (NANOG) has been reported to activate the transcription of SLC23A2 gene in HESC condition, which leads to an increased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
PBX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC23A2 gene in ovarian cancer condition | [17] | ||||
TF Protein Name |
Pre-B-cell leukemia transcription factor 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Pre-B-cell leukemia transcription factor 1 (PBX1) has been reported to activate the transcription of SLC23A2 gene in ovarian cancer condition, which leads to an increased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
POU2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [2] | ||||
TF Protein Name |
POU domain, class 2, transcription factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
POU domain, class 2, transcription factor 1 (POU2F1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
ZEB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [5] | ||||
TF Protein Name |
Zinc finger E-box-binding homeobox 1 | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger E-box-binding homeobox 1 (ZEB1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
E2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC23A2 gene in MCF7 cells | [18] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) has been reported to bind to the transcription of SLC23A2 gene in MCF7 cells, which leads to an affected expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [1] | ||||
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [2] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Liver; Pancreatic ductal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC23A2 gene | [9] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of SLC23A2 gene in . condition, which leads to a affected expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
FLI1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC23A2 gene in megakaryocytes condition | [19] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) has been reported to bind to the transcription of SLC23A2 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC23A2 gene | [1] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
MYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [3] | ||||
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional activator Myb (MYB) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC23A2 gene | [3] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Adrenal gland; Blood; Bone marrow; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class6.1: Rel homology region factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFKB1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC23A2 gene in enterotoxigenic Escherichia coli infection condition | [20] | ||||
TF Protein Name |
Nuclear factor NF-kappa-B p105 subunit | Transcription Factor Info | ||||
Affected Drug/Substrate |
Ascorbic acid | |||||
Studied Phenotype |
Enterotoxigenic Escherichia coli infection [ICD11: 1A03.1] | |||||
Tissue |
Jejunum | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
BALB/c mice | |||||
Detailed Description |
Nuclear factor NF-kappa-B p105 subunit (NFKB1) has been reported to repress the transcription of SLC23A2 gene in enterotoxigenic Escherichia coli infection condition, which leads to a decreased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Transcriptional Phenomenon2 |
Repression of SLC23A2 gene in brain neuroblastoma condition | [11] | ||||
TF Protein Name |
Nuclear factor NF-kappa-B p105 subunit | Transcription Factor Info | ||||
Affected Drug/Substrate |
Ascorbic acid | |||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Nuclear factor NF-kappa-B p105 subunit (NFKB1) has been reported to repress the transcription of SLC23A2 gene in brain neuroblastoma condition, which leads to a decreased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TP53 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC23A2 gene in health condition | [21] | ||||
TF Protein Name |
Cellular tumor antigen p53 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Ascorbic acid | |||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Embryo | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
mouse embryo fibroblast cell isolates | |||||
Detailed Description |
Cellular tumor antigen p53 (TP53) has been reported to repress the transcription of SLC23A2 gene in health condition, which leads to a decreased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
TP63 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC23A2 gene in epithelial to mesenchymal transition condition | [22] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC23A2 gene in epithelial to mesenchymal transition condition, which leads to an affected expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Transcriptional Phenomenon2 |
Binding to SLC23A2 gene in health condition | [23] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC23A2 gene in health condition, which leads to an affected expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC23A2 gene in hESCs | [24] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to activate the transcription of SLC23A2 gene in human embryonic stem cells (hESCs), which leads to an increased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.